CBLL logo

CBLL CeriBell, Inc.

NASDAQ Global Select · Medical - Devices · Healthcare

$26.74
-1.06 (-3.81%)

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in ur…

Market Cap: $1.04Bceribell.com

Price

No data yet.

Social Signal Score

52
5d
60
1 mentions
—
30d
49
7 mentions
—
60d
49
7 mentions
—
90d
49
7 mentions
—
news: 7

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0
Avg price target$27.5+2.8%
Low $26Median $27.5High $29
Current Consensus

Revenue

$29.34M+186.49%
$10.24M$16.61M$22.97M$29.34M
Mar 2023Sep 2026

Analyst Estimates

FY2025
$-1.51
$-1.59–$-1.46
7 analysts
FY2026
$-2.08
$-2.13–$-1.89
6 analysts
FY2027
$-1.76
$-1.87–$-1.44
6 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Xingjuan Chao
Sector
Healthcare
Industry
Medical - Devices
Employees
327
Beta
0.86
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
14.33
ceribell.com